Reform Urgent

India stands at a crossroads in the global clinical trials market. Despite its vast and diverse patient pool, cost-effective medical ecosystem, and expanding hospital network, the country holds a mere 8 per cent share in global trials, significantly lagging behind China’s 29 per cent and America's 25 per cent.